# Hypothermic Oxygenated Perfusion for Extended Criteria Donors in Liver Transplantation (HOPExt)

> **NCT03929523** · NA · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 266 (actual)

## Conditions studied

- Liver Transplantation

## Interventions

- **DEVICE:** End-ischemic Hypothermic Oxygenated Machine Perfusion (HOPE)
- **DEVICE:** classic static cold storage

## Key facts

- **NCT ID:** NCT03929523
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-10
- **Primary completion:** 2023-03-13
- **Final completion:** 2023-03-13
- **Target enrollment:** 266 (ACTUAL)
- **Last updated:** 2025-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03929523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03929523, "Hypothermic Oxygenated Perfusion for Extended Criteria Donors in Liver Transplantation (HOPExt)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03929523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*